Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

INVITED SPEAKER AND ORAL PRESENTATIONS

INVITED SPEAKER AND ORAL PRESENTATIONS New avenues in technologies and tools Scott C. Fahrenkrug Unversity of Minnesota, Department of Animal Sciences, Animal Biotechnology Center, St. Paul, MN, USA The Mayo Experience Barry S. Wiseman Mayo Clinic - Division of Transplantation, Rochester, MN, USA Current approaches in aminal husbandry for minimizing the risk of transmission of infectious agents M. Michael Swindle Medical Unversity of South Carolina, Department of Comparative Medicine, Charleston, SC, USA New avenues in technologies and tools Eckhard Wolf University of Munich, Institute of Molecular Animal Breeding and Biotchnology, Gene Center, Munich, Germany Regulatory update: source animals for xenotransplantation clinical trials Eda Bloom FDA, Center for Biologics Evaluation & Research, Division of Cellualr & Genetherapy, Bethesda, MD, USA Artificial chromosomes, prospects for xenotransplantation Dirk Schindelhauer Human Artificial Chromosome Group, Life Sciences Center Weihenstephan, TUM, Freising, Germany 100 CELL PROCESSING, PRESERVATION, PRETREATMENT AND PRODUCT TESTING 100.1 Islet cells JosØ Oberholzer* University of Illinois at Chicago, IL, USA What needs to be targeted? Anthony JF d'Apice St Vincent's Health, Immunology Research Center & Department of Clinicial Immunology, Fitzroy, VIC, Australia Pathogens to remove Jack Risdahl The Integra Group, Brooklyn Park, MN, USA Human hepatocyte isolation under GMP conditions for clinical transplantation Anil Dhawan*, Ragai http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Xenotransplantation Wiley

INVITED SPEAKER AND ORAL PRESENTATIONS

Xenotransplantation , Volume 14 (5) – Sep 1, 2007

Loading next page...
 
/lp/wiley/invited-speaker-and-oral-presentations-1dGhwFHTgH

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
Copyright © 2007 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0908-665X
eISSN
1399-3089
DOI
10.1111/j.1399-3089.2007.00426.x
pmid
17803509
Publisher site
See Article on Publisher Site

Abstract

New avenues in technologies and tools Scott C. Fahrenkrug Unversity of Minnesota, Department of Animal Sciences, Animal Biotechnology Center, St. Paul, MN, USA The Mayo Experience Barry S. Wiseman Mayo Clinic - Division of Transplantation, Rochester, MN, USA Current approaches in aminal husbandry for minimizing the risk of transmission of infectious agents M. Michael Swindle Medical Unversity of South Carolina, Department of Comparative Medicine, Charleston, SC, USA New avenues in technologies and tools Eckhard Wolf University of Munich, Institute of Molecular Animal Breeding and Biotchnology, Gene Center, Munich, Germany Regulatory update: source animals for xenotransplantation clinical trials Eda Bloom FDA, Center for Biologics Evaluation & Research, Division of Cellualr & Genetherapy, Bethesda, MD, USA Artificial chromosomes, prospects for xenotransplantation Dirk Schindelhauer Human Artificial Chromosome Group, Life Sciences Center Weihenstephan, TUM, Freising, Germany 100 CELL PROCESSING, PRESERVATION, PRETREATMENT AND PRODUCT TESTING 100.1 Islet cells JosØ Oberholzer* University of Illinois at Chicago, IL, USA What needs to be targeted? Anthony JF d'Apice St Vincent's Health, Immunology Research Center & Department of Clinicial Immunology, Fitzroy, VIC, Australia Pathogens to remove Jack Risdahl The Integra Group, Brooklyn Park, MN, USA Human hepatocyte isolation under GMP conditions for clinical transplantation Anil Dhawan*, Ragai

Journal

XenotransplantationWiley

Published: Sep 1, 2007

There are no references for this article.